Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 113

1.

Patient-Reported Outcomes of Quality of Life, Functioning, and GI/Psychiatric Symptom Severity in Patients with Inflammatory Bowel Disease (IBD).

IsHak WW, Pan D, Steiner AJ, Feldman E, Mann A, Mirocha J, Danovitch I, Melmed GY.

Inflamm Bowel Dis. 2017 May;23(5):798-803. doi: 10.1097/MIB.0000000000001060.

PMID:
28301432
2.

Responsiveness to Change and Minimally Important Differences of the Patient-Reported Outcomes Measurement Information System Gastrointestinal Symptoms Scales.

Khanna D, Hays RD, Shreiner AB, Melmed GY, Chang L, Khanna PP, Bolus R, Whitman C, Paz SH, Hays T, Reise SP, Spiegel B.

Dig Dis Sci. 2017 May;62(5):1186-1192. doi: 10.1007/s10620-017-4499-9. Epub 2017 Mar 1.

PMID:
28251500
3.

Risk for Overall Infection with Anti-TNF and Anti-integrin Agents Used in IBD: A Systematic Review and Meta-analysis.

Shah ED, Farida JP, Siegel CA, Chong K, Melmed GY.

Inflamm Bowel Dis. 2017 Apr;23(4):570-577. doi: 10.1097/MIB.0000000000001049.

PMID:
28230558
4.

Fostering Collaboration Through Creation of an IBD Learning Health System.

Johnson LC, Melmed GY, Nelson EC, Holthoff MM, Weaver SA, Morgan TS, Siegel CA.

Am J Gastroenterol. 2017 Mar;112(3):406-408. doi: 10.1038/ajg.2017.9. Epub 2017 Feb 14. No abstract available.

PMID:
28195179
5.

O-008 YI The Impact of A Nurse Navigator Program on Telephone Calls and Emergency Department Utilization Among IBD Patients.

Kapur A, Divakaran S, Walsh C, Nguyen A, Alacantra C, Anda J, Curry Y, Adams P, Melmed G.

Inflamm Bowel Dis. 2017 Feb;23 Suppl 1:S3. doi: 10.1097/01.MIB.0000512518.91833.a7.

PMID:
28125556
6.

ACG Clinical Guideline: Preventive Care in Inflammatory Bowel Disease.

Farraye FA, Melmed GY, Lichtenstein GR, Kane SV.

Am J Gastroenterol. 2017 Feb;112(2):241-258. doi: 10.1038/ajg.2016.537. Epub 2017 Jan 10.

PMID:
28071656
7.

Effects of caregiver burden on quality of life and coping strategies utilized by caregivers of adult patients with inflammatory bowel disease.

Parekh NK, Shah S, McMaster K, Speziale A, Yun L, Nguyen DL, Melmed G, Kane S.

Ann Gastroenterol. 2017;30(1):89-95. doi: 10.20524/aog.2016.0084. Epub 2016 Sep 6.

8.

Gastrointestinal symptom severity in irritable bowel syndrome, inflammatory bowel disease and the general population.

Lee AD, Spiegel BM, Hays RD, Melmed GY, Bolus R, Khanna D, Khanna PP, Chang L.

Neurogastroenterol Motil. 2017 May;29(5). doi: 10.1111/nmo.13003. Epub 2016 Dec 16.

PMID:
27981684
9.

A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study of Brodalumab in Patients With Moderate-to-Severe Crohn's Disease.

Targan SR, Feagan B, Vermeire S, Panaccione R, Melmed GY, Landers C, Li D, Russell C, Newmark R, Zhang N, Chon Y, Hsu YH, Lin SL, Klekotka P.

Am J Gastroenterol. 2016 Nov;111(11):1599-1607. doi: 10.1038/ajg.2016.298. Epub 2016 Aug 2.

PMID:
27481309
10.

Assessment of Gaps in Care and the Development of a Care Pathway for Anemia in Patients with Inflammatory Bowel Diseases.

Hou JK, Gasche C, Drazin NZ, Weaver SA, Ehrlich OG, Oberai R, Zapala S, Siegel CA, Melmed G.

Inflamm Bowel Dis. 2017 Jan;23(1):35-43. doi: 10.1097/MIB.0000000000000953.

PMID:
27749376
11.

Knowledge, Attitudes, and Beliefs Regarding the Role of Nutrition in IBD Among Patients and Providers.

Tinsley A, Ehrlich OG, Hwang C, Issokson K, Zapala S, Weaver A, Siegel CA, Melmed GY.

Inflamm Bowel Dis. 2016 Oct;22(10):2474-81. doi: 10.1097/MIB.0000000000000901.

PMID:
27598738
12.

Many Inflammatory Bowel Disease Patients Are Not Immune to Measles or Pertussis.

Cleveland NK, Rodriquez D, Wichman A, Pan I, Melmed GY, Rubin DT.

Dig Dis Sci. 2016 Oct;61(10):2972-6. doi: 10.1007/s10620-016-4275-2. Epub 2016 Aug 24.

PMID:
27557706
13.

Early remission status predicts long-term outcomes in patients with Crohn's disease treated with certolizumab pegol.

Melmed GY, McGovern D, Schreiber S, Kosutic G, Spearman M, Coarse J, Sandborn WJ.

Curr Med Res Opin. 2016 Dec;32(12):1937-1941. Epub 2016 Aug 22.

PMID:
27494777
14.

Outcomes with Anti-Tumour Necrosis Factor-Alpha Therapy and Serology in Patients with Denovo Crohn's Disease After Ileal Pouch Anal Anastomosis.

Robbins L, Zaghiyan K, Melmed G, Vasiliauskas E, Ahmed S, McGovern D, Rabizadeh S, Singh N, Landers C, Ippoliti A, Shih D, Targan S, Fleshner P.

J Crohns Colitis. 2017 Jan;11(1):77-83. doi: 10.1093/ecco-jcc/jjw134. Epub 2016 Jul 27.

PMID:
27466172
15.

How Relative Value Units Undervalue the Cognitive Physician Visit: A Focus on Inflammatory Bowel Disease.

Katz S, Melmed G.

Gastroenterol Hepatol (N Y). 2016 Apr;12(4):240-4. No abstract available.

16.

Appropriateness of Testing for Anti-Tumor Necrosis Factor Agent and Antibody Concentrations, and Interpretation of Results.

Melmed GY, Irving PM, Jones J, Kaplan GG, Kozuch PL, Velayos FS, Baidoo L, Sparrow MP, Bressler B, Cheifetz AS, Devlin SM, Raffals LE, Vande Casteele N, Mould DR, Colombel JF, Dubinsky M, Sandborn WJ, Siegel CA.

Clin Gastroenterol Hepatol. 2016 Sep;14(9):1302-9. doi: 10.1016/j.cgh.2016.05.010. Epub 2016 May 14.

PMID:
27189916
17.

Recommendations for Quality Colonoscopy Reporting for Patients with Inflammatory Bowel Disease: Results from a RAND Appropriateness Panel.

Devlin SM, Melmed GY, Irving PM, Rubin DT, Kornbluth A, Kozuch PL, Raffals LE, Velayos FS, Sparrow MP, Baidoo L, Bressler B, Cheifetz AS, Jones J, Kaplan GG, Siegel CA.

Inflamm Bowel Dis. 2016 Jun;22(6):1418-24. doi: 10.1097/MIB.0000000000000764.

PMID:
27057680
18.

Clinical Factors Associated with the Development of Crohn's Disease in Inflammatory Bowel Disease-unclassified Patients Undergoing Ileal Pouch-anal Anastomosis.

Koh SZ, Zaghiyan KN, Li Q, Rabizadeh S, Melmed GY, Targan SR, Fleshner PR.

Inflamm Bowel Dis. 2016 Jun;22(6):1397-402. doi: 10.1097/MIB.0000000000000744.

PMID:
26978722
19.

Perianal Crohn's Disease is Associated with Distal Colonic Disease, Stricturing Disease Behavior, IBD-Associated Serologies and Genetic Variation in the JAK-STAT Pathway.

Kaur M, Panikkath D, Yan X, Liu Z, Berel D, Li D, Vasiliauskas EA, Ippoliti A, Dubinsky M, Shih DQ, Melmed GY, Haritunians T, Fleshner P, Targan SR, McGovern DP.

Inflamm Bowel Dis. 2016 Apr;22(4):862-9. doi: 10.1097/MIB.0000000000000705.

20.

Evaluating Study Withdrawal Among Biologics and Immunomodulators in Treating Ulcerative Colitis: A Meta-analysis of Controlled Clinical Trials.

Shah ED, Siegel CA, Chong K, Melmed GY.

Inflamm Bowel Dis. 2016 Apr;22(4):933-9. doi: 10.1097/MIB.0000000000000680.

PMID:
26818417

Supplemental Content

Loading ...
Support Center